Infantile hypertrophic pyloric stenosis in patients with esophageal atresia

Chantal A Ten Kate1, Rutger W W Brouwer2, Yolande van Bever3

  • 1Department of Pediatric Surgery and Intensive Care Children, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands.

Birth Defects Research
|April 17, 2020
PubMed

Insights

Genetic analysis of patients with esophageal atresia (EA) and infantile hypertrophic pyloric stenosis (IHPS) revealed rare inherited variants, suggesting complex inheritance rather than a single genetic cause for this combined condition.

Area of Science:

  • Developmental biology
  • Medical genetics
  • Pediatric surgery

Background:

  • Esophageal atresia (EA) and infantile hypertrophic pyloric stenosis (IHPS) co-occur more frequently than expected, suggesting a shared underlying cause.
  • Both conditions affect foregut-derived structures, hinting at a common developmental etiology.
  • Genetic factors are implicated in EA and IHPS individually and as components of various genetic syndromes.

Purpose of the Study:

  • To investigate the genetic basis for the co-occurrence of EA and IHPS.
  • To identify genetic variations contributing to the combined EA/IHPS phenotype.

Main Methods:

  • Exome sequencing and SNP array genotyping were performed on 15 patients with EA and IHPS and their unaffected parents.
  • Genetic data were compared with mouse foregut transcriptome data during development.

Main Results:

  • No deleterious de novo or recessive mutations were found.
  • Rare inherited variants in genes associated with EA, IHPS, or foregut morphogenesis were identified.
  • Enrichment analysis highlighted pathways involved in smooth muscle cell proliferation/differentiation and satellite cell self-renewal.

Conclusions:

  • A single monogenetic cause does not fully explain the EA/IHPS combination.
  • Complex inheritance, potentially interacting with mechanical and environmental factors, is the most likely explanation.
  • Further research into the impact of corrective surgery on the EA/IHPS phenotype is warranted.
Abstract

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
502
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
333
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
646
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
368
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
479
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
299